Abstract:The ideal biomaterial for the repair of bone defects is expected to have good mechanical properties, be fabricated easily into a desired shape, support cell attachment, allow controlled release of bioactive factors to induce bone formation, and biodegrade into nontoxic products to permit natural bone formation and remodeling. The synthetic polymer poly(propylene fumarate) (PPF) holds great promise as such a biomaterial. In previous work we developed poly(DL-lactic-co-glycolic acid) (PLGA) and PPF microspheres for the controlled delivery of bioactive molecules. This study presents an approach to incorporate these microspheres into an injectable, porous PPF scaffold. Model drug Texas red dextran (TRD) was encapsulated into biodegradable PLGA and PPF microspheres at 2 microg/mg microsphere. Five porous composite formulations were fabricated via a gas foaming technique by combining the injectable PPF paste with the PLGA or PPF microspheres at 100 or 250 mg microsphere per composite formulation, or a control aqueous TRD solution (200 microg per composite). All scaffolds had an interconnected pore network with an average porosity of 64.8 +/- 3.6%. The presence of microspheres in the composite scaffolds was confirmed by scanning electron microscopy and confocal microscopy. The composite scaffolds exhibited a sustained release of the model drug for at least 28 days and had minimal burst release during the initial phase of release, as compared to drug release from microspheres alone. The compressive moduli of the scaffolds were between 2.4 and 26.2 MPa after fabrication, and between 14.9 and 62.8 MPa after 28 days in PBS. The scaffolds containing PPF microspheres exhibited a significantly higher initial compressive modulus than those containing PLGA microspheres. Increasing the amount of microspheres in the composites was found to significantly decrease the initial compressive modulus. The novel injectable PPF-based microsphere/scaffold composites developed in this study are promising to serve as vehicles for controlled drug delivery for bone tissue engineering.

Controlled Drug Release From Biodegradable Bone Fillers

Antibiotic-containing Biodegradable Bead Clusters with Porous PLGA Coating As Controllable Drug-Releasing Bone Fillers.

Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles

Scaffold composed of porous vancomycin-loaded poly(lactide-co-glycolide) microspheres: A controlled-release drug delivery system with shape-memory effect

Controlled-release Implant System Formulated Using Biodegradable Hemostatic Gauze As Scaffold.

Controlled release of a non-steroidal anti-inflammatory drug from a photocurable polymeric calcium phosphate cement

Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)

A Novel of Biodegradable Implants Based on Plga for Control Delivery of Cisplatin

Hydroxyapatite/Poly (butylene Succinate)/Metoprolol Tartrate Composites with Controllable Drug Release and a Porous Structure for Bone Scaffold Application

Controlled Release of Clodronate from PLA/PCL Complex Microsphere

Biopolymeric Coatings for Local Release of Therapeutics from Biomedical Implants

Fabrication and Characterization of Poly-D-l-lactide/nano-hydroxyapatite Composite Scaffolds with Poly (ethylene Glycol) Coating and Dexamethasone Releasing

Synthesis, Characterization And Osteoconductivity Properties Of Bone Fillers Based On Alendronate-Loaded Poly(Epsilon-Caprolactone)/Hydroxyapatite Microspheres

Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs

Construction of macroporous magnesium phosphate-based bone cement with sustained drug release

Dual-functional polyetheretherketone surface with programmed sequential drug release coating

Surface Coating of Poly-D-L-Lactide/Nano-Hydroxyapatite Composite Scaffolds for Dexamethasone-Releasing Function and Wettability Enhancement

A drug eluting poly(trimethylene carbonate)/poly(lactic acid)-reinforced nanocomposite for the functional delivery of osteogenic molecules

Comparison of the properties of implantable matrices prepared from degradable and non-degradable polymers for bisphosphonate delivery

Self-expanding PMMA composite bone cement with sustained release of gentamicin sulfate and alendronate using water absorption pathways

Prolonged Release from PLGA/HAp Scaffolds Containing Drug-Loaded PLGA/gelatin Composite Microspheres